Get started
Author

Sarah W.Y. Lok

Observed names: Sarah Lok, Sarah W Y Lok, Sarah W. Y. Lok, Sarah Wing Yan Lok, Sarah Wing-yan Lok, Sarah W.Y. Lok
ORCID: 0000-0002-8587-4086
Observed ORCID: 0000-0002-8587-4086
OpenAlex ID: A5005801002
Activated renal tubular Wnt/β-catenin signaling triggers renal inflammation during overload proteinuria
2018 · Dickson W.L. Wong, Wai Han Yiu, et al. · Kidney International · 72
Tubular β-catenin alleviates mitochondrial dysfunction and cell death in acute kidney injury
2022 · Hongyu Li, Joseph C. K. Leung, et al. · Cell Death and Disease · 53
PDF
Amelioration of Endoplasmic Reticulum Stress by Mesenchymal Stem Cells via Hepatocyte Growth Factor/c-Met Signaling in Obesity-Associated Kidney Injury
2019 · Bin Li, Joseph C. K. Leung, et al. · Stem Cells Translational Medicine · 42
PDF
The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis
2020 · Sarah W.Y. Lok, Wai Han Yiu, et al. · Clinical Science · 35
Protective role of kallistatin in renal fibrosis via modulation of Wnt/β-catenin signaling
2021 · Wai Han Yiu, Ye Li, et al. · Clinical Science · 33
Long Non-coding RNA NEAT1, NOD-Like Receptor Family Protein 3 Inflammasome, and Acute Kidney Injury
2024 · Rui Xue, Wai Han Yiu, et al. · Journal of the American Society of Nephrology · 29
Potential Therapeutic Targets of Rehmannia Formulations on Diabetic Nephropathy: A Comparative Network Pharmacology Analysis
2022 · Kam Wa Chan, Kam Yan Yu, et al. · Frontiers in Pharmacology · 20
PDF
The long noncoding RNA Meg3 mediates TLR4-induced inflammation in experimental obstructive nephropathy
2023 · Wai Han Yiu, Sarah W.Y. Lok, et al. · Clinical Science · 17
Patients’ and clinicians’ expectations on integrative medicine Services for Diabetes: a focus group study
2020 · Kam Wa Chan, Pak Wing Lee, et al. · BMC Complementary Medicine and Therapies · 16
PDF
Tubule-specific deletion of LincRNA-p21 ameliorates lipotoxic kidney injury
2021 · Bin Li, Joseph C.K. Leung, et al. · Molecular Therapy — Nucleic Acids · 11
PDF
AI-Driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic Agent
2024 · Qiuqiong Tang, Deyong Xiao, et al. · Aging and Disease · 10
PDF
Tubulovascular protection from protease-activated receptor-1 depletion during AKI-to-CKD transition
2023 · Sarah W Y Lok, Wai Han Yiu, et al. · Nephrology Dialysis Transplantation · 8
PDF
Tubular FoxP2 and Kidney Fibrosis
2024 · Yixin Zou, Wai Han Yiu, et al. · Journal of the American Society of Nephrology · 5
Long non-coding RNA Neat1 promotes acute kidney disease via activation of NLRP3 inflammasome
2022 · Sydney Tang, Rui Xue, et al. · Research Square · 1
PDF
C5a/C5aR1 mediates AKI–CKD transition by enhancing autophagy
2026 · Jingyuan Ma, Wai Han Yiu, et al. · Nephrology Dialysis Transplantation
Cover Image
2024 · Rui Xue, Wai Han Yiu, et al. · Journal of the American Society of Nephrology
Protease-Activated Receptor-1 Deficiency Protects Against Glomerular and Endothelial Injury in Type 2 Diabetic Nephropathy
2023 · Sarah W.Y. Lok, Wai Han Yiu, et al. · Journal of the American Society of Nephrology
The Pathogenic Role of C5a/C5aR Axis in AKI-to-CKD Transition
2023 · Jingyuan Ma, Wai Han Yiu, et al. · Journal of the American Society of Nephrology
TSPO Mediates Tubulointerstitial Fibrosis and Kidney Inflammation After Unilateral Ureteral Obstruction
2023 · Yuchen Feng, Wai Han Yiu, et al. · Journal of the American Society of Nephrology
Bone Marrow-Derived C5aR Contributes to Kidney Inflammation and Tubulointerstitial Fibrosis in Streptozotocin (STZ)-Induced Diabetic Nephropathy
2022 · Jingyuan Ma, Wai Han Yiu, et al. · Journal of the American Society of Nephrology
Transcription Factor Foxp2 Promotes TGF-β1-Induced Kidney Fibrosis in Obstructive Nephropathy
2022 · Yixin Zou, Wai Han Yiu, et al. · Journal of the American Society of Nephrology
Tubulovascular Protection of Protease-Activated Receptor-1 Deficiency During AKI-to-CKD Transition
2022 · Sarah W.Y. Lok, Wai Han Yiu, et al. · Journal of the American Society of Nephrology
Role of PAR-1 in Immune Activation and Tubulointerstitial Fibrosis During AKI-to-CKD transition
2021 · Sarah W.Y. Lok, Wai Han Yiu, et al. · Journal of the American Society of Nephrology
The PAR-1 Antagonist Vorapaxar Protects Against AKI to CKD Transition
2020 · Sarah W.Y. Lok, Wai Han Yiu, et al. · Journal of the American Society of Nephrology
Lipopolysaccharide Induces NEAT 1 Expression in AKI via TLR4/NF-κB Signaling
2020 · Rui Xue, Wai Han Yiu, et al. · Journal of the American Society of Nephrology
Works count: 25
Citation count: 352
H-index: 10
I10-index: 11
Year
Topic
Type